Hm Payson & CO 10x Genomics, Inc. Transaction History

Hm Payson & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$55.7 - $145.79 $6,294 - $16,474	-113 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$135.05 - $182.59 $13,910 - $18,806	103 Added 1030.0%	113 $17,000
Q2 2021 Aug 17, 2021	SELL	$134.22 - $202.37 $31,407 - $47,354	-234 Reduced 95.9%	10 $2,000
Q4 2020 Mar 10, 2021	BUY	$126.47 - $163.7 $3,414 - $4,419	27 Added 12.44%	244 $35,000
Q3 2020 Dec 21, 2020	BUY	$87.44 - $125.0 $18,974 - $27,125	217 New	217 $27,000

291

94.7M

263K

85.1K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.5B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

Stay updated on Hm Payson & CO with notifications on news.